New Research Reveals Higher Levels of PFAS in Fetal Blood

Recent research from Mount Sinai has revealed that fetuses likely have significantly higher levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as "forever chemicals," in their blood than previously understood. The study analyzed 120 umbilical cord blood samples, employing a non-targeted analysis that identified 42 different PFAS compounds, compared to the limited testing methods that typically focus on only a few common compounds like PFOA and PFOS. Shelley Liu, a co-author of the study and associate professor at the Icahn School of Medicine at Mount Sinai, emphasized the importance of these findings, stating, “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”

The Guardian

PFAS are a class of over 15,000 compounds used in various products for their water-, stain-, and grease-resistant properties. These chemicals have been linked to numerous health issues, including cancer, birth defects, decreased immunity, high cholesterol, and kidney disease. The study highlights that fetuses are particularly vulnerable to these substances, as elevated PFAS levels in mothers correlate with higher infant mortality rates, low birth weights, and obesity later in life. Furthermore, fetal exposure has been associated with long-term health problems such as cancer, neurological issues, and cardiovascular disease.

The Guardian

The findings raise concerns about the adequacy of current regulatory testing methods. The U.S. Environmental Protection Agency (EPA) has traditionally focused on a limited number of PFAS compounds, with recent certifications allowing testing for 53 compounds. However, Liu noted that Mount Sinai's analysis identified 31 compounds not included in the EPA's testing parameters. This discrepancy suggests that the true extent of PFAS contamination may be underestimated, as independent researchers have found thousands of PFAS in water sources that regulators do not routinely monitor.

The Guardian

David Andrews, acting chief science officer at the Environmental Working Group, a non-profit organization not involved in the study, criticized the current regulatory framework. He stated, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.” The study did not directly assess health outcomes, leaving the implications of higher PFAS levels in fetal blood somewhat unclear, but the association with increased health risks remains a significant concern.

The Guardian

The Mount Sinai study underscores the need for improved regulatory measures and testing methods to address the widespread presence of PFAS in the environment and its potential health impacts on vulnerable populations, particularly fetuses. As researchers continue to investigate the health implications of these findings, the call for more stringent oversight and comprehensive testing becomes increasingly urgent.

The Guardian